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Evidence  presented  in  a  previous  paper  (1)  suggested  that  cell-mediated 
immunity  (CMI) 1 was  essential for  the  process  of  recovery from  mousepox. 
However, the nature of the antiviral mechanisms involved in this process have 
not been defined. 
Recently,  Mackaness has demonstrated that in mice acquired resistance to 
an  intracellular bacterial parasite, Listeria  monocytogenes,  can  be  transferred 
with  spleen cells from  immune  donors  (2).  In this model there  is sound  evi- 
dence  that  CMI  plays  an  essential  part  in  the  generation  of  antibacterial 
mechanisms,  although  the  ultimate  effectors  of  resistance  are  macrophages 
with enhanced but nonspecific microbicidal activity. In view of these findings, 
it appeared that passive transfer experiments should provide further informa- 
tion  concerning  the  role  of  CMI-dependent  mechanisms  in  recovery  from 
mousepox. 
Materials and Methods 
General.--Details of the stocks of virulent (Moscow strain) and avirulent (Hampstead egg 
strain) ectromelia virus, and of rabbit anti-mouse  thymocyte serum  (ATS), and assays for 
virus plaque-forming  units (PFU), neutralizing antibody, interferon,  and hypersensitivity to 
viral antigens were given in a previous paper (1). 
Animals.--C57BL  mice were employed in most experiments;  CBA mice were used  only 
where indicated in the text. Mice of the same age (6-10 wk), sex, and strain were employed in 
individual experiments. 
Spleen Cell Suspensions.--Spleens  were cut into pieces and pressed through stainless steel 
sieves into ice-cold Eagle's minimal essential  medium  containing 2% fetal calf serum. After 
dissociation of clumps by pipetting, the suspensions were filtered once through tightly packed 
3 X 0.5 cm cotton-wool columns (2), washed three times in Puck's A saline, and suspended for 
injection in Puck's A saline containing 5 IU of heparin/mL Viability of the final suspensions 
was assessed by trypan blue (0.50/0) exclusion. It was usually between 75 and 90%. 
1  Abbreviations used in this paper: ATS, rabbit anti-mouse  thymocyte serum;  CMI, cell- 
mediated immunity; NMS, normal mouse serum;  NRS,  normal rabbit serum;  PFU, virus 
plaque-forming  units. 
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A nti-Ectromelia Serum.--The hyperimmune serum pool has been described in the preceding 
paper (1). In repeated assays the ectromelia neutralization titer was 1:4000. 
Mouse Interferon.--The  stock preparation of mouse brain interferon, stimulated by West 
Nile virus, contained 400 units/ml. 
Bacterla.--The  strain of Listeria monocytogenes  used has been described elsewhere  (3). It was 
virulent for the mouse (intravenous LD~0 approximately 5 )< 104 in C57BL mice). Bacteria were 
grown in tryptic soy broth (Difco Laboratories Inc., Detroit, Mich.); log phase cultures were 
dispersed by ultrasound and diluted in Hanks' balanced salt solution with 1% fetal calf serum 
for injection into mice. Plate counts of viable bacteria were performed on tryptic soy agar 
(Difco). The method for enumeration of viable bacteria in individual mouse spleens has been 
given previously (3). 
Anti-Light  Chair~ Serum.--Rabbit antiserum  against  the light chains of mouse immuno- 
globulins was kindly provided by Dr. Noel Warner. 
Anti-Theta  Asdtic Fluid.--Ascitic  fluid obtained from AKR mice immunized with CBA 
mouse thymocytes was generously provided by Dr. N. A. Mitchison through Professor Gordon 
Ada. 
Guinea Pig  Complement.--Lyophylized  guinea pig complement  (Commonwealth  Serum 
Laboratories,  Melbourne,  Australia)  was  reconstituted,  absorbed  with  CBA  thymocytes 
(which removed lyric activity against mouse cells), and stored at -- 20°C. 
Irradiation.--Mice  were placed in small, circular plastic cages on a rotating stage 20 cm 
from a 6°Co source of gamma rays. Dose rate at this distance was 19.8 rads/min. Controls were 
subjected to a similar confining treatment without being irradiated. 
RESULTS 
Passive  Transfer of Recovery Mechanisms with  Immune Spleen Cells.- 
General procedure: Donors of immune spleen cells were immunized intravenously with 5 )< 
105 PFU avirulent ectromelia virus. Cell recipients were infected intravenously with 2 )<  105 
PFU virulent ectromelia virus 24 hr before cell transfer so that progressive infection was estab- 
lished in fiver parenchyma (4) at the time of injection of cells. Since control of infection in the 
liver is essential for recovery from primary mousepox (5), the impact of immune cells upon the 
course of infection was quantified by titrating virus in the liver and spleen at intervals after cell 
transfer. Although the effects of immune cells in recipients were followed for several days in 
early experiments, the titers of virus in liver and spleen 24 hr after cell transfer  (48 hr after 
infection) were finally chosen as indicators of antiviral activity. This time sequence avoided the 
participation of the active response of the recipient, since the virus grew unchecked over the 1st 
48 hr after injection. 
Preliminary  results:  Immune  spleen  ceils  possessed  significant  antiviral 
activity  if harvested  between  4  and  10  days  after  donor  immunization,  but 
most  of  this  activity was  lost  by  day  20.  Normal  spleen  cells were  inactive. 
The  amount  of  avirulent  virus  in  immune  spleen  cell inocula  was  highest  in 
4-day  immune  cells  (4)<  10' PFU/5  )<  l0  T cells)  and  declined rapidly  there- 
after,  thus  immune  cell  injections  made  no  significant  contribution  to  virus 
titers in the recipients. 
The  following  series  of  experiments,  in  which  6-day  immune  donors  were 
used,  were designed  to  elucidate  the  essential  antiviral  properties  of  immune 
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Effects of Intact Immune Calls,  Disrupted Immune Cells, or Serum from 6-day 
Immune Cell Donors.-- 
Spleen cells were harvested from immune donors and divided into two portions. One portion 
was treated with ultrasound for 20 see so that no intact cells remained as determined by micro- 
scopic examination. Disrupted or intact viable cells (4 X  10Z/reeipient) were then injected 
intravenously into separate groups of five preinfected recipients. Another group of five recip- 
ientswas given an intravenous injection of serum (0.5 ml/mouse) from the immune cell donors, 
while a control group was left untreated. An additional group of controls was included to deter- 
mine virus titers at the time of cell transfer; all other mice were sacrificed 24 hr after cell trans- 
fer. 
TABLE  I 
Effect of Intact Immune Spleen Cells, Disrupted Immune Spleen Cells, or Serum from Immune 
Cell Donors on Virus  Titers* in the Livers and Spleens of Recipients Infected I.V. with 
2 )  105 PFU Virulent Ectromelia Virus 24 Hr before Adoptive Immunization 
Time after treatment 
Treatment~  0 hr  24 hr 
Liver  Spleen  Liver  Spleen 
Intact immune cells  --  --  2.7  4-  0.2§  1.7  4-  0.6[] 
Disrupted immune cells  --  --  6.4  4-  0.2  5.1  4-  1.2 
Immune serum  --  --  6.1  4-  0.3  5.5  4-  0.7 
Nil  4.6  -4-  0.2  4.4  4-  0.2  6.1  4-  0.3  5.2  4-  0.8 
* Expressed as mean log PFU per organ 4- standard deviations in groups of five mice. 
Donors of immune cells and serum were immunized i.v. with 5 X  106 PFU avirulent 
ectromelia virus 6 days previously. Doses are given in the text. 
§ Significantly less than all other liver counts (P <  0.001). 
][ Significantly less than all other spleen counts (P <  0.01). 
Neither  disrupted immune  cells nor the serum of ceU donors possessed  anti- 
viral  activity  (Table  I).  Therefore,  the  fall  in  virus  titers  in  the  livers  and 
spleens of recipients of intact immune cells depended upon the cells functioning 
within the recipients, not upon preformed factors contained within them. 
Interferon  and  Neutralizing  Antibody  Production  in  Recipients  of  Immune 
Spleen Cells.-- 
A  group  of eight preinfected recipients was injected intravenously with viable immune 
spleen cells (7 X  107/mouse).  Control groups, each of eight mice, received 6  X  107 normal 
spleen cells or nothing. 10 and 24 hr later, subgroups of four mice were sacrificed and their 
livers and spleens removed for virus titration. Spleens were snap-frozen in liquid N2 to preserve 
interferon (6), and after samples from each mouse had been diluted for virus titration, the 
crude spleen homogenates of each group were pooled and processed for interferon assays. At 24 
hr after cell transfer, serum samples were also obtained from individual mice of each group and 
assayed for neutralizing antibody. 
Table  II  shows  that  while  significant  antiviral  activity  was  evident  in  the 
livers  and  spleens  of  immune  cell  recipients,  neutralizing  antibody  was  un- R.  V.  BLANDEN  1077 
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detectable in all their individual sera tested at the minimum practicable dilu- 
tion,  and interferon was not present in  their spleens. However, splenic inter- 
feron was readily detected in mice which did not receive immune spleen cells. 
Effects  of  Passively  Administered  Hyperimmune  Serum  and  Interferon.- 
The preceding experiment gave no indication of the amount of antibody which 
might be required to achieve the degree of antiviral activity exhibited by im- 
mune  spleen  cells,  and  again  showed  that  virus  growth  occurred  despite  a 
splenic  interferon  response,  as  demonstrated  previously  (1).  Therefore  the 
effects of  passively  administered hyperimmune  mouse  anti-ectromelia serum 
and interferon were investigated. 
Groups of five preinfected recipients were given intravenous injections of 0.2 ml/mouse of 
hyperimmune serum or of interferon (80 units). Control groups received either 0.2 ml of normal 
TABLE  III 
Effect of Hyperimmune  Serum and Interferon on  Virus  Titers*  in  Recipient$  Target Organs 
Dose  Treatment  i.v./mouse 
Time after serum and interferon  injection 
0 hr  24 hr 
Neutra- 
Liver  Spleen  Liver  Spleen  lizing 
antibody§ 
Hyperimmune serum  0.2 ml  --  --  5.1 4- 0.4[[  4.6 4- 0.4¶  100 4- 61 
Normal serum  0.2 ml  --  --  7.2 4- 0.3  6.5 4- 0.3  <tO 
Interferon  80 units  --  --  7.2 4- 0.2  6.5 4- 0.3  -- 
Nil  --  5.4 4- 0.3  4,6 :t: 0.3  7.0 4- 0.3  6.2 4- 0.8  -- 
* Expressed  as mean log PFU per liver or spleen  -4- standard deviations  in groups of five mice. 
:~ Recipients  were  injected  i.v. with 2 )< 105 PFU virulent ectromelia  virus 24 br before  serum  and interferon 
injection. 
§ Means of reciprocals  of titers 4- standard deviations  in groups  of five mice. 
II Significantly  less than all other liver counts (P < 0.001). 
¶ Significantly  less than all other spleen counts (P < 0.05). 
mouse serum or nothing. Livers and spleens of all recipients were removed for virus titration 
24 hr later. Recipients of normal and immune serum were also bled for neutralizing antibody 
assays at this time. 
The  dose  of  interferon  administered was  without  effect  on  virus  titers  in 
the organs of recipients (Table III).  On the other hand, hyperimmune serum 
achieved significant control of virus  in  both liver  and  spleen. However,  this 
effect  of  immune  serum  seemed  markedly  less  than  the  effects  of  immune 
spleen cells (Tables I,  II)  despite the fact that immune serum recipients pos- 
sessed neutralizing antibody in their serum at a  titer probably 10 times greater 
than immune spleen cell recipients. 
A  similar  experiment  showed  that  serum  from  donors  immunized  with 
avirulent  virus  9  days  before  bleeding,  conferred significantly less  antiviral 
activity than  hyperimmune serum.  Therefore, hyperimmune  serum was used R.  V.  BLANDEN  1079 
in  further  evaluation  of  the  importance  of  antibodies  in  recovery.  Direct 
comparison  of  the  effects  of  hyperimmune serum  and  immune spleen  cells 
will be described in a later section. 
Transfer  of  Hypersensitivity  to  Ectromelia  Virus  Antigens  with  Immune 
Cells  and Immune Serum.--The  foregoing evidence suggested that the major 
antiviral activity of immune spleen cells was not related to the production of 
antibody or interferon in recipients. Therefore an experiment was performed 
to  determine  whether  cells  capable  of  mediating  delayed  hypersensitivity 
reactions to viral antigens were present in 6-day immune spleen cell populations, 
and to compare the characteristics of hypersensitivity reactions conferred upon 
recipients by immune cells and hyperimmune serum. 
TABLE IV 
Transfer of Hypersensitivity to Ectromelia Virus Antigens with Immune Spleen Cells or Hyper- 
immune Serum 
Treatment  of recipients 
Hypersensitivity* 
3 hr  6 hr  9 hr  24 hr 
Immune cellsi.v.~  0  0.1  4-  0.2  0.1  4-  0.2  1.7  4-  0.4§ 
Immune serum i.v.  1.5  4-  0.7§  0.2  q-  0.4  0.1  4-  0.2  0.1  4-  0.2 
Immune cells f.p.:~  0.4  4-  0.5  0.6  4-  0.411  1.0  4-  0.6§  0.7  4-  0.6 
* Means of specific increases in foot thickness (in 0.1 mm units)  4-  standard deviations 
in groups of five mice. 
Harvested  from donors immunized i.v. with 5 )<  105 PFU avirulent ectromelia virus 6 
days previously. Doses are given in the text. f.p., into the footpad. 
§ Significant specific reaction (P <  0.02). 
H P  <  o.o5. 
A dose of 1.2 X  108 viable immune spleen cells/mouse was injected intravenously into a 
group of five mice; controls received 1.1 X  10  s normal spleen cells. Another group of five mice 
was given hyperimmune mouse anti-ectromelia serum intravenously  (0.2 ml/mouse);  their 
control group received 0.2 ml of normal mouse serum. All mice were then tested by footpad 
inoculation for hypersensitivity to ectromelia virus antigens within 30 min of the receipt of 
cells or serum. A further group of five mice  was injected in the right hind foot with 0.04 ml of 
a mixture of equal parts of the immune cell suspension (6 X  106 cells/mouse) and the virus 
antigen suspension; controls received a mixture of normal spleen cells and antigens. 
The control groups provided a measure of the nonspecific foot swelling caused 
by injection trauma.  The specific swelling due  to  hypersensitivity was  then 
obtained by  subtraction of  control figures  from  those  of  the  corresponding 
test groups to give the  results shown in Table IV. Immune spleen cells con- 
ferred  significant delayed  (24  hr)  hypersensitivity reactions  upon  recipients 
but  no immediate  (3  hr)  hypersensitivity. Intravenous injection of  cells  re- 
sulted in the largest swellings occurring at 24 hr, while local injection into the 
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tained at 9  hr.  In contrast,  immune serum transfer produced significant im- 
mediate hypersensitivity but no delayed reactions. Thus, it is clear that the 
immune cell population contained effective mediators of CMI, but the trans- 
ferred cells produced insufficient antibody to cause immediate hypersensitivity 
reactions to ectromelia antigens. 
Specificity  of Adoptive Immunity Conferred by Immune Spleen Cells.--If  the 
antiviral activity  of  imnmne spleen  cells  depends  upon  CMI,  it  should  be 
specific,  i.e.,  immune  cell  populations  with  demonstrable  specific  activity 
against other  antigens should be inactive against ectromelia virus,  and vice 
versa. Therefore, spleen cells from mice immunized with Listeria monocytogenes 
were used in an experiment which was designed to test the specificity of ectro- 
melia-immune cells. 
A group of mice was immunized intravenously with 1.1 X  1@ viable Listeria. Survivors 
were used 6 days later as donors of Listeria-immune spleen cells. Another group of mice donated 
ectromelia-immune spleen cells 6 days after intravenous immunization with 5 X  105 PFU 
avirulent  virus. Six groups of four recipients were employed. Three groups were infected intra- 
venously with 2 X 105 PFU virulent ectromelia virus 24 hr before cell transfer; the other three 
groups were infected intravenously with 1.5 X  105 viable Listeria at the time of cell transfer. 
One ectromelia-infected and one Listerla-infected group received 1.3 X l0  s viable ectromelia- 
immune spleen cells intravenously/mouse;  a second group from each infected pool received 
1.4 X  108 viable Listeria-immune cells intravenously/mouse;  the remaining groups served as 
controls for each infectious agent and were given no cells. Spleens of all Listeria-infected mice 
were removed for viable bacterial counts 24 hr after cell transfer. Livers were not taken since 
the spleen provides a more sensitive indication of the anti-Listeria activity of immune spleen 
cells (2). Spleens and livers of all ectromelia-infected mice were also removed at this time for 
virus titration. 
Listeria-immune  cells exhibited potent anti-Listeria  activity but their anti- 
ectromelia activity was negligible (Table V).  In contrast, ectromelia-immune 
cells were active against ectromelia virus but  inactive  against  Listeria,  thus 
demonstrating their specificity. 
The Effects of A TS and Anti-Light  Chain Serum upon the Antiviral Activity 
of Immune Spleen Cells.--Specifically  commited lymphocytes mediating anti- 
bacterial resistance are inactivated by treatment with heterologous ATS  (7). 
Therefore,  similar cells  responsible for  antiviral mechanisms should  also  be 
susceptible to  ATS.  Furthermore,  recent  work  in vitro  (8)  and  in vivo  (9) 
suggests that on the surfaces of the specifically sensitized lymphocytes active 
in  CMI  there  are  receptors  for  antigen which  can  be  blocked  by  antibody 
directed against immunoglobulin  light chains. Thus, if the antiviral activity of 
immune spleen cells is due to CMI,  it should be blocked by anti-light chain 
serum. These predictions were tested in the following experiment. 
A suspension of ectromelia-immune spleen cells in Puck's A saline was divided into four 
portions; to the first three portions, either anti-light chain serum, ATS, or normal rabbit serum 
(NRS) was added to give a final serum dilution of 1:4. These three suspensions were then R.  V.  BLANDEN  1081 
placed in an ice bath together with a  fourth untreated control. All cell suspensions were re- 
moved from the ice bath after 2 hr, washed twice in Puck's A  saline, examined for viability, 
and injected intravenously into groups of four preinfected recipient mice for each suspension. 
Because of the limited supply of anti-llght chain serum, only small numbers of cells could be 
treated. Therefore, the dose of viable cells per recipient (2 X  107) was lower than in previous 
experiments. A  fifth group of control recipients received no cells. All five groups were then 
sacrificed for virus titrations on their livers and spleens 24 br after cell transfer, 
Table VI indicates that  the antiviral activity of immune spleen  cells  was 
abrogated  by  treatment  with  ATS  or  anti-light  chain  serum.  Thus,  these 
TABLE  V 
Specificity of Adoptive Immunity Conferred  by Immune Spleen Cells: Effects on Listeria mono- 
cytogenes  and Ectromelia  Virus Infections* in Recipient  Target Organs  24 Hr after Cell 
Transfer 
Immune cell:~ specificity 
Listeria-infected}  Ectromelia-infected mice]!  mice 
Spleen counts  Liver PFU  Spleen PFU 
Listerla-immune  3.7  4-  0.2 ¶  7.3  4-  0.4  7.3  4-  0.4 
Ectromelia-immune  6.3  4-  0.2  4.8  4-  0.7**  5.9  4-  0.7~:~ 
Nil  6.6  4-  0.1  7.7  4-  0.3  7.6  4-  0.2 
* As indicated by mean log viable bacteria per organ 4- standard  deviations, and mean 
log virus PFU per organ 4- standard deviations in groups of four mice. 
2~ Details of donor immunization and cell doses are given in the text. 
§ Listeria-infected recipients were given  1.5  X  105 viable £isteria i.v. at  the time of cell 
transfer. 
11 Ectromelia-infected recipients were given 2  X  10  ~ PFU virulent virus i.v. 24 hr before 
cell transfer. 
¶  Significantly less than both other groups (P  <  0.001). 
** P  <  0.01. 
~  P  <  0.05. 
results  are  consistent with the contention that the major antiviral effect of 
immune spleen cells depends upon specifically sensitized lymphocytes. 
Effect of Anti-Theta Ascitic Fluid on the Antiviral Activity of Immune Spleen 
Cells.--Antibodies  against  the  thymus-specific,  theta  antigen  (10)  afford  a 
means of defining the roles of thymus-derived lymphocytes in immune phe- 
nomena. Recent reports  suggest that the specifically sensitized effector cells 
in CMI are thymus-derived (11,  12). Therefore, if antiviral activity conferred 
by immune spleen cells is CMI-dependent, it should be absent from cell popu- 
lations in which the  thymus-derived cells  have been inactivated. Anti-theta 
ascitic fluid was used to test this possibility. 
Equal numbers of spleen cells from 6-day immune CBA donors were suspended in either 
anti-theta ascitic fluid or normal mouse serum (NMS) and incubated at 37°C for 30 min. The 
cells were then washed twice in Puck's A  saline, resuspended in a  1:2 dilution of guinea pig 1082  PASSIVE  TRANSFER  OF  RECOVERY  MECHANISMS  IN  MOUSEPOX 
complement in Hanks' balanced salt solution, and again incubated at 37°C for 30 min. These 
two suspensions, together with a third control suspension which had been kept in an ice bath, 
were washed twice in Puck's A saline, examined for viability, and injected intravenously into 
groups of four preinfected CBA recipients. Apparent viability of complement-treated ceils was 
TABLE  VI 
Effects  of Anti-Light Chain Serum and A TS on the Ant±viral Activity* of Immune Spleen  Cells 
Treatment of  Posttreatment %  Dose of viable  Virus titers 24 hr after cell transfer 
immune cells~  viability  of intact  cells/mouse  ceils  Liver  Spleen 
Anti-light chain  62  1.9  X  107  7.9  -4-  0.3§  7.0  4-  0.21[ 
serum 
ATS  73  2.1  X  107  8.1  -4.  0.2¶  7.0  -4.  0.1"* 
NRS  72  2.0  X  107  7.2  4-  0.4  6.2  -4.  0.5 
Nil  70  1.9  X  107  7.0  -4.  0.3  5.7  ±  0.4 
--  --  Nil  7.9  -4.  0.4  7.2  :t=  0.4 
* As indicated by mean log PFU per organ -4.  standard deviations in groups  of four re- 
cipients infected i.v. with 2  X  105 PFU virulent ectromelia virus  24 hr before cell transfer. 
2~ Harvested from donors immunized i.v. with 5  X  105 PFU  avirulent ectromelia virus 6 
days previously. Treatment details are given in the text. 
§ Significantly greater than "Nil"  (P  <  0.02). 
t] Significantly greater than "NRS"  (P  <  0.05)  and "Nil"  (P  <  0.02). 
¶  Significantly greater than "NRS"  (P  <  0.02)  and "Nil"  (P  <  0.01). 
** Significantly greater than both "NRS"  and "Nit"  (P  <  0.02). 
TABLE  VII 
Effect of Anti-There Ascitic Fluid on the Ant±viral Activity*  of Immune Spleen  Cells 
Treatment of  Posttreatment %  Dose of viable  Virus titers 24 hr after cell transfer 
immune cells:~  viability  of intact  cells/mouse  cells  Liver  Spleen 
Anti-theta ascitic  96  1.3  X  107  8.3  -4.  0.1§  9.4  -4.  0.4§ 
fluid 
NMS  96  1.1  X  107  6.6  4-  0.7  8.2  4-  0.6 
Nil  82  1.6  X  107  6.8  -4.  0.7  8.4  -4.  0.3 
--  --  --  8.2  -4.  0.5  9.5  :t:  0.2 
* As indicated by mean log PFU per liver or spleen 4- standard deviations in groups of 
four recipients  infected  i.v.  with  2  X  105  PFU  virulent ectromelia  virus 24 hr before  cell 
transfer. 
:~ Harvested  from  donors immunized i.v.  with  5  >(  105  PFU  avirulent  ectromelia  virus 
6 days previously. Treatment details are given in the text. 
§ Significantly greater  than  "NMS"  (P  <  0.02)  and  "Nil"  (P  <  0.05). 
abnormally high, probably because dead ceils were completely lysed and thus not detectable by 
dye uptake. As in the previous experiment, only a small number of cells could be treated in the 
volume of anti-theta ascitic fluid available, so that the dose of viable cells per recipient was 
1-2 X  107. A fourth group of control CBA recipients were given no cells. Virus titrations were 
performed on the livers and spleens of all recipients 24 hr after cell transfer. R.  V.  BLANDEN  1083 
Immune cell populations treated  with anti-theta  antibodies  completely lost 
their  antiviral  activity  (Table VII), a  result  consistent with an essential  role 
for thymus-derived lymphocytes. 
Effect of Irradiation on Antiviral Mechanisms in Recipients  of Immune Spleen 
Cells or Hyperimmune  Serum.--Blood  monocytes  appear  to  be  essential  for 
the development of CMI-dependent antibacterial resistance in foci of infection 
caused by intracellular  bacterial parasites  (13,  14).  Therefore,  it seemed  rea- 
sonable  to  expect  that  antiviral  mechanisms  would  also  involve  monocytes. 
Irradiation doses as low as 400 rads cause severe depletion of blood monocytes 
within 24 hr (15). This effect was utilized in the following experiment. 
A group of 20 mice was given 800 rads whole body gamma-irradiation  immediately before 
intravenous infection with 2 X  105 PFU virulent ectromelia virus. After 24 hr, subgroups of 
five mice together  with groups of five unirradiated,  infected controls were injected  intrave- 
nously with  1.2 X  l0  s viable ectromelia-immune spleen cells/mouse, or with hyperimmune 
anti-ectromelia serum (0.2 ml/mouse). After a further 24 hr these mice were sacrificed for virus 
titration of their livers and spleens, and serum neutralizing antibody determinations.  The  10 
remaining irradiated,  infected mice and 10 unirradiated,  infected mice served as controls re- 
ceiving neither immune cells nor immune serum; five mice of each group were sacrificed for ti- 
tration of virus in the liver and spleen at the time of cell and serum transfer,  and the remain- 
ing five were used 24 hr later. 
Irradiated mice given no other treatment had significantly higher virus titers 
in the liver  (P  <  0.01)  than unirradiated  controls both at the time of cell or 
serum transfer and 24 hr later,  i.e. 24 and 48 hr after infection, whereas spleen 
titers  were  not  significantly  different  (P  >  0.10)  (Table  VIII).  Irradiation 
of  recipients  almost  completely  repressed  the  expression  of  antiviral  ac- 
tivity conferred by immune serum.  This  effect was less complete in recipients 
of immune cells. The significance of repression was determined by an analysis 
of variance test  comparing the changes in virus titers  in irradiated  and unir- 
radiated  recipients  over  the  24  hr  period  after  adoptive  immunization.  Re- 
pression  of the  effects  of both  immune  cells  and  immune  serum  was highly 
significant ill the spleen  (P  <  0.01)  and liver  (P  <  0.001).  These results are 
readily explained by the assumption of an important role for recipient mono- 
cytes  in the  expression  of antiviral  activity.  The  less  complete  repression  in 
the recipients of immune cells could then be due to either the direct antiviral 
activity  of specifically  sensitive  lymphocytes,  or  to partial  reconstitution  of 
recipient monocyte levels.  The latter  possibility seems  unlikely  since there  is 
evidence  that  the  spleen  is  not  a  significant  source  of  monocytes  in  other 
systems (14,  16-18). 
Finally,  immune  spleen  cells  were  far  more  efficient  in  controlling  virus 
multiplication  in  recipient  target  organs  than  high  titer  immune  serum,  al- 
though  neutralizing  antibody was  undetectable  in  the  sera  of cell  recipients 
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The  Antiviral  Activity  of  an  Immune  Spleen  Cell  Population  Depleted  of 
Mononuclear Phagocytes.--The  data presented to this point imply that thymus- 
derived, specifically sensitized lymphocytes play an essential role in the passive 
transfer  of  antiviral  activity by  immune  spleen  cells,  but  indicate  that  full 
expression of this activity may depend upon recipient monocytes. The follow- 
ing  experiment  was  performed  to  determine  whether  significant  antiviral 
activity also resided in mononuclear phagocytes present in immune cell popu- 
lations. 
TABLE  VIII 
Effect  of Irradiation  on Antiviral  Mechanisms*  in  Recipients  of  Immune Spleen  Cells or 
Hyperimmune  Serum 
Time  after cell or serum  injections 
Treatment  of  0  hr  24 hr 
Neutra- 
recipients~  Liver  Spleen  Liver  Spleen  lizing 
antibody§ 
PFU  P'LI  PFU  PII 
Irradiation  +  --  --  4.8  4-  1.3  <0.01  5.6  4-  0.6  <0.05  <10 
immune  cells 
Irradiation  ~-  --  --  7.3  4-  0.2  <0.01  6.9  4-  0.2  N.S.¶  224 4-  88 
immune  serum 
Irradiation  5.6  4-  0.2  4.9  4-  0.6  7.9  4-  0. I  --  6.9  4-  0.2  --  -- 
Immune  cells  --  --  1.5  4-  0.3  <0.001  2.9  4-  1.0  <0.01  <10 
Immune  serum  --  --  4.6  4-  1.0  <0.01  4.4  4-  1.0  <0.01  256  4-  88 
Nil  4.9  4-  0.2  4.4  4-  0.5  6.9  4-  0.4  --  6.7  4-  0.4  --  -- 
* As  indicated  by  mean  log PFU  per liver or spleen -4- standard  deviations  in groups  of five  recipients  in- 
fected i.v. with 2  X  105 PFU  virulent eetromelia virus 24 hr before cell and serum  transfer. 
Immune  spleen  ceils were  harvested  from  donors  immunized  i.v. with 5  X  105 PFU  avirulent  ectromelia 
virus 6 days previously.  Doses of immune cells and immune serum, and irradiation details are given in the text. 
§ Reciprocals of titers -4-  standard  deviations  in groups  of five mice. 
[I Values  of probability,  P,  derived from  t  test  of the  significance of the difference  between  means  of  test 
groups  and  appropriate  irradiated or untreated  control group. 
¶  N.S., not  significant  (P >  0.05). 
A crude suspension of 6-day immune  spleen cells was dispersed by pipetting, passed once 
through loosely packed cotton to remove remaining clumps, washed once in Puck's A saline, 
and divided into two portions. One suspension was passed seven times through tightly packed 
3 )< 0.5 cm cotton columns at 20°C while the other remained in an ice bath. When samples of 
the two suspensions were cultured in Eagle's medium with 10% fetal calf serum, it was found 
that the seven passages through cotton columns had eliminated mononuclear phagocytes, i.e., 
mononuclear cells capable of adherence and spreading on glass. The two cell suspensions were 
each injected intravenously into groups of four preinfected recipients.  Virus  tltrations on 
recipient livers and spleens were performed 24 hr later. 
The  results  in  Table  IX  indicate  that  rigorous  removal  of  mononuclear 
phagocytes from the immune spleen cell population did not impair its antiviral 
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DISCUSSION 
Recovery from mousepox depends upon the control of virus growth in the 
liver (5). Therefore, passive transfer experiments were designed to investigate 
the antiviral mechanisms involved in this process. 
Preliminary experiments showed that the spleens of donor mice which had 
been immunized intravenously with  avirulent virus contained cells with  sig- 
nificant antiviral potential at least as soon as the 4th day. Immune cell ac- 
tivity was maintained virtually unchanged until the 10th day but waned sig- 
nificantly by day 20.  These results are in agreement with previous evidence 
(1) which indicated that recovery mechanisms began to operate in the spleen 
and liver 4-6 days after subcutaneous infection with virulent virus. 
TABLE  IX 
The Antiviral Activity* of an Immune Spleen Cell Population Depleted of Mononuclear  Phago- 
cytes 
Treatment of immune  Dose of viable 
eellsI  cells/mouse 
Virus titers 24 hr after cell transfer 
Liver  Spleen 
Monocyte depletion  5.3  4-  l0  T  3.0  4- 0.2§  2.4  4-  0.41[ 
Nil  5.1  X  10  ~  3.0  4- 0.3§  2.5  4- 0.511 
--  --  7.2  4-  0.3  7.2  4-  0.9 
* As indicated by mean log PFU per liver or spleen 4- standard deviations in groups of 
four recipients  infected  i.v.  with  2  X  105  PFU  virulent ectromelia virus 24  hr before  cell 
transfer. 
:~ Harvested from donors immunized i.v. with 5  X  105 PFU avirulent ectromelia virus 6 
days previously. The monocyte depletion procedure is described in the text. 
§ Less than control (P <  0.001). 
11 P  <  o.ol. 
Immune  ceils did  not  contain preformed factors  which  could  account for 
their activity, since sonically disrupted  cells were inactive  (Table I).  In ad- 
dition, antiviral activity was not accompanied by the production of detectable 
neutralizing  antibody or splenic interferon in  immune  cell recipients  (Table 
II).  Passively  administered  interferon  was  ineffective  (Table  III),  while 
immune sera conferred less antiviral activity than immune  cells (Tables I-III 
and VIII) but higher neutralizing antibody titers (Tables II, III, and  VIII). 
In  fact,  the  neutralizing  antibody  titers  of  hyperimmune  serum  recipients 
were far greater than those generated in mice which had recovered from pri- 
mary infection (1). However, this level of serum antibody only prevented fur- 
ther multiplication of virus over a 24 hr interval, and did not cause a  signifi- 
cant drop in titers (Tables III, VIII). 
The foregoing data contraindicate important roles for interferon and neu- 
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in an earlier paper (1) which suggested an essential role for CMI in the recovery 
process. Further evidence on this question was obtained in the present experi- 
ments and is summarized in the following five points. 
(a)  The  cellular  mediators  of  delayed  hypersensitivity  to  virus  antigens 
were present in immune spleen cell populations,  since mice given these cells 
intravenously mounted significant delayed reactions when tested in  the  foot 
(Table IV).  Cells  secreting free antibody to virus  antigens  could have been 
present  in  this  immune  population,  but  their  activity was  not  sufficient to 
produce  immediate  hypersensitivity  reactions  in  recipients,  even  when  the 
cells were injected directly into the test site together with antigens. In contrast, 
mice  which  received  an  intravenous  injection  of  hyperimmune  serum  gave 
significant immediate reactions. 
(b)  The antiviral mechanism conferred by immune cells was specific (Table 
V). 
(c)  Complete inhibition of the antiviral activity of immune cells was achieved 
by treatment in vitro with ATS,  or anti-theta  ascitic fluid plus complement 
(Tables VI,  VII),  thus  suggesting  that  the  effective cells  in  the  population 
were thymus-derived. This conforms with the results of Williams and Waksman 
(11)  and  Cerottini,  Nordin,  and  Brunner  (12)  who  have  recently obtained 
results  which  suggest  that  the  specifically sensitized  cells  in  CMI  in  other 
systems  are  thymus-derived.  Furthermore,  this  evidence  argues  against  an 
important  antiviral function for antibody-secreting cells.  These cells are not 
thymus-derived lymphocytes in systems so far elucidated in the mouse (19, 20). 
(d)  Treatment of immune  cells with  rabbit  anti-mouse  light  chain  serum 
completely inhibited their antiviral activity (Table VI). There is evidence that 
the  specificity of sensitized  lymphocytes depends  upon  an  immunoglobulin- 
like surface receptor for antigen and that heterologous antisera directed against 
the light chains of immunoglobulins may block these receptors, thus rendering 
the cells unresponsive to antigen (8, 9). 
(e)  Extensive filtration of immune  spleen  cell populations  which  removed 
all  mononuclear  phagocytes  left  antiviral  activity  unimpaired  (Table  IX). 
In  summary,  these  results  strongly  suggest  that  specifically  sensitized, 
thymus-derived lymphocytes are mainly  responsible for the  efficient mecha- 
nisms of recovery transferred by immune spleen cells.  However, they do not 
elucidate  the  nature  of  these  antiviral  mechanisms.  The  use  of  recipients 
which  had  been  irradiated  (800  rads)  24  hr  before  adoptive  immunization 
provided information on this question. These animals were unable to express 
fully  the  antiviral  activity  of  immune  spleen  cells  or  hyperimmune  serum 
(Table VIII),  thus indicating that radio-sensitive recipient components played 
an important role. 
The  available  evidence  suggests  that  blood  monocytes  are  the  recipient 
components concerned. These cells are generated mainly in bone marrow by the R.  V.  BLANDEN  1087 
division of radiosensitive progenitors (16,  17). Within 24 hr of irradiation there 
is marked depletion of blood monocytes and almost complete suppression of 
delayed-hypelsensitivity reactions  (15)  in  which  bone  marrow-derived  cells 
comprise the  bulk  of the  cellular infiltration  (18,  21).  Irradiation  also  sup- 
presses  the  development  of  CMI-dependent  antibacterial  resistance  which 
requires a  monocytic invasion of infectious loci (13,  14).  Therefore, it seems 
likely that  in  the normal  recipient mice used  in  the  present  experiments,  a 
monocytic invasion  of virus-infected foci, triggered by specifically sensitized 
lymphocytes, occurred over the 24 hr interval after immune cell transfer. After 
immune serum transfer, monocytes might enter infectious foci as a  sequel to 
acute  inflammation  (17,  22)  provoked  by  antigen-antibody  complexes,  or 
possibly as  a  result of passive sensitization by adsorbed cytophilic antibody 
(23). 
The possible  roles of lymphocytes and rnonocytes in the recovery process 
will be discussed further in the accompanying paper (24). 
SUMMARY 
The following passive transfer experiments evaluated the  contributions  of 
the various host responses in recovery from mousepox. (a) Immune spleen cells 
transferred  highly  efficient antiviral  activity,  but  preinfected  recipients  of 
these cells made no detectable splenic interferon or antibody in the 24 hr in- 
terval after cell transfer. (b) Passively administered interferon was ineffective. 
(c) Recipients of hyperimmune serum had much more antibody than recipients 
of  immune  spleen  cells but  significantly less  antiviral  activity.  (d)Immune 
spleen cell populations with antiviral activity contained mediators of CMI to 
virus antigens.  (e) The antiviral activity of immune spleen cells was specific; 
it was inhibited by in vitro treatment with ATS, anti-light chain serum, and 
anti-theta ascitic fluid, but not by removal of mononuclear phagocytes from 
the immune population. 
These results are interpreted to mean that recovery mechanisms conferred 
by  immune  spleen  cells  were  triggered  by  specifically  sensitized,  thymus- 
derived lymphocytes, and that antibody and interferon responses were of less 
importance. A  radiosensitive recipient component was  necessary for the full 
expression of the antiviral activity of both immune cells and immune serum. 
It seemed likely that this component was the blood monocyte. 
I would like to thank Miss Ann Robertson for her competent technical assistance. 
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